Development of a virulent O'nyong'nyong challenge model to determine heterologous protection mediated by a hydrogen peroxide-inactivated chikungunya virus vaccine.

Saved in:
Bibliographic Details
Title: Development of a virulent O'nyong'nyong challenge model to determine heterologous protection mediated by a hydrogen peroxide-inactivated chikungunya virus vaccine.
Authors: Weber WC; Vaccine & Gene Therapy Institute, Oregon Health & Science University, Beaverton, Oregon, United States of America.; Division of Pathobiology & Immunology, Oregon National Primate Research Center, Oregon Health & Science University, Beaverton, Oregon, United States of America., Streblow ZJ; Vaccine & Gene Therapy Institute, Oregon Health & Science University, Beaverton, Oregon, United States of America.; Division of Pathobiology & Immunology, Oregon National Primate Research Center, Oregon Health & Science University, Beaverton, Oregon, United States of America., Andoh TF; Vaccine & Gene Therapy Institute, Oregon Health & Science University, Beaverton, Oregon, United States of America.; Division of Pathobiology & Immunology, Oregon National Primate Research Center, Oregon Health & Science University, Beaverton, Oregon, United States of America., Denton M; Vaccine & Gene Therapy Institute, Oregon Health & Science University, Beaverton, Oregon, United States of America.; Division of Pathobiology & Immunology, Oregon National Primate Research Center, Oregon Health & Science University, Beaverton, Oregon, United States of America., Raué HP; Division of Neuroscience, Oregon National Primate Research Center, Oregon Health & Science University, Beaverton, Oregon, United States of America., Amanna IJ; Najít Technologies, Inc., Beaverton, Oregon, United States of America., Slifka DK; Najít Technologies, Inc., Beaverton, Oregon, United States of America., Kreklywich CN; Vaccine & Gene Therapy Institute, Oregon Health & Science University, Beaverton, Oregon, United States of America.; Division of Pathobiology & Immunology, Oregon National Primate Research Center, Oregon Health & Science University, Beaverton, Oregon, United States of America., Arduino I; Department of Clinical and Biological Sciences, University of Turin, Orbassano, Italy., Sulgey G; Vaccine & Gene Therapy Institute, Oregon Health & Science University, Beaverton, Oregon, United States of America.; Division of Pathobiology & Immunology, Oregon National Primate Research Center, Oregon Health & Science University, Beaverton, Oregon, United States of America., Streblow MM; Vaccine & Gene Therapy Institute, Oregon Health & Science University, Beaverton, Oregon, United States of America., Heise MT; Department of Microbiology & Immunology, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, United States of America., Slifka MK; Division of Neuroscience, Oregon National Primate Research Center, Oregon Health & Science University, Beaverton, Oregon, United States of America., Streblow DN; Vaccine & Gene Therapy Institute, Oregon Health & Science University, Beaverton, Oregon, United States of America.; Division of Pathobiology & Immunology, Oregon National Primate Research Center, Oregon Health & Science University, Beaverton, Oregon, United States of America.
Source: PLoS neglected tropical diseases [PLoS Negl Trop Dis] 2025 Mar 17; Vol. 19 (3), pp. e0012938. Date of Electronic Publication: 2025 Mar 17 (Print Publication: 2025).
Publication Type: Journal Article
Journal Info: Publisher: Public Library of Science Country of Publication: United States NLM ID: 101291488 Publication Model: eCollection Cited Medium: Internet ISSN: 1935-2735 (Electronic) Linking ISSN: 19352727 NLM ISO Abbreviation: PLoS Negl Trop Dis Subsets: MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
FullText Links:
  – Type: pdflink
Text:
  Availability: 1
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 40096126
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Development of a virulent O'nyong'nyong challenge model to determine heterologous protection mediated by a hydrogen peroxide-inactivated chikungunya virus vaccine.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Weber+WC%22">Weber WC</searchLink>; Vaccine & Gene Therapy Institute, Oregon Health & Science University, Beaverton, Oregon, United States of America.; Division of Pathobiology & Immunology, Oregon National Primate Research Center, Oregon Health & Science University, Beaverton, Oregon, United States of America.<br /><searchLink fieldCode="AU" term="%22Streblow+ZJ%22">Streblow ZJ</searchLink>; Vaccine & Gene Therapy Institute, Oregon Health & Science University, Beaverton, Oregon, United States of America.; Division of Pathobiology & Immunology, Oregon National Primate Research Center, Oregon Health & Science University, Beaverton, Oregon, United States of America.<br /><searchLink fieldCode="AU" term="%22Andoh+TF%22">Andoh TF</searchLink>; Vaccine & Gene Therapy Institute, Oregon Health & Science University, Beaverton, Oregon, United States of America.; Division of Pathobiology & Immunology, Oregon National Primate Research Center, Oregon Health & Science University, Beaverton, Oregon, United States of America.<br /><searchLink fieldCode="AU" term="%22Denton+M%22">Denton M</searchLink>; Vaccine & Gene Therapy Institute, Oregon Health & Science University, Beaverton, Oregon, United States of America.; Division of Pathobiology & Immunology, Oregon National Primate Research Center, Oregon Health & Science University, Beaverton, Oregon, United States of America.<br /><searchLink fieldCode="AU" term="%22Raué+HP%22">Raué HP</searchLink>; Division of Neuroscience, Oregon National Primate Research Center, Oregon Health & Science University, Beaverton, Oregon, United States of America.<br /><searchLink fieldCode="AU" term="%22Amanna+IJ%22">Amanna IJ</searchLink>; Najít Technologies, Inc., Beaverton, Oregon, United States of America.<br /><searchLink fieldCode="AU" term="%22Slifka+DK%22">Slifka DK</searchLink>; Najít Technologies, Inc., Beaverton, Oregon, United States of America.<br /><searchLink fieldCode="AU" term="%22Kreklywich+CN%22">Kreklywich CN</searchLink>; Vaccine & Gene Therapy Institute, Oregon Health & Science University, Beaverton, Oregon, United States of America.; Division of Pathobiology & Immunology, Oregon National Primate Research Center, Oregon Health & Science University, Beaverton, Oregon, United States of America.<br /><searchLink fieldCode="AU" term="%22Arduino+I%22">Arduino I</searchLink>; Department of Clinical and Biological Sciences, University of Turin, Orbassano, Italy.<br /><searchLink fieldCode="AU" term="%22Sulgey+G%22">Sulgey G</searchLink>; Vaccine & Gene Therapy Institute, Oregon Health & Science University, Beaverton, Oregon, United States of America.; Division of Pathobiology & Immunology, Oregon National Primate Research Center, Oregon Health & Science University, Beaverton, Oregon, United States of America.<br /><searchLink fieldCode="AU" term="%22Streblow+MM%22">Streblow MM</searchLink>; Vaccine & Gene Therapy Institute, Oregon Health & Science University, Beaverton, Oregon, United States of America.<br /><searchLink fieldCode="AU" term="%22Heise+MT%22">Heise MT</searchLink>; Department of Microbiology & Immunology, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, United States of America.<br /><searchLink fieldCode="AU" term="%22Slifka+MK%22">Slifka MK</searchLink>; Division of Neuroscience, Oregon National Primate Research Center, Oregon Health & Science University, Beaverton, Oregon, United States of America.<br /><searchLink fieldCode="AU" term="%22Streblow+DN%22">Streblow DN</searchLink>; Vaccine & Gene Therapy Institute, Oregon Health & Science University, Beaverton, Oregon, United States of America.; Division of Pathobiology & Immunology, Oregon National Primate Research Center, Oregon Health & Science University, Beaverton, Oregon, United States of America.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22101291488%22">PLoS neglected tropical diseases</searchLink> [PLoS Negl Trop Dis] 2025 Mar 17; Vol. 19 (3), pp. e0012938. <i>Date of Electronic Publication: </i>2025 Mar 17 (<i>Print Publication: </i>2025).
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Public+Library+of+Science%22">Public Library of Science </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>101291488 <i>Publication Model: </i>eCollection <i>Cited Medium: </i>Internet <i>ISSN: </i>1935-2735 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2219352727%22">19352727 </searchLink><i>NLM ISO Abbreviation: </i>PLoS Negl Trop Dis <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=40096126
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1371/journal.pntd.0012938
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: e0012938
    Titles:
      – TitleFull: Development of a virulent O'nyong'nyong challenge model to determine heterologous protection mediated by a hydrogen peroxide-inactivated chikungunya virus vaccine.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Weber WC
      – PersonEntity:
          Name:
            NameFull: Streblow ZJ
      – PersonEntity:
          Name:
            NameFull: Andoh TF
      – PersonEntity:
          Name:
            NameFull: Denton M
      – PersonEntity:
          Name:
            NameFull: Raué HP
      – PersonEntity:
          Name:
            NameFull: Amanna IJ
      – PersonEntity:
          Name:
            NameFull: Slifka DK
      – PersonEntity:
          Name:
            NameFull: Kreklywich CN
      – PersonEntity:
          Name:
            NameFull: Arduino I
      – PersonEntity:
          Name:
            NameFull: Sulgey G
      – PersonEntity:
          Name:
            NameFull: Streblow MM
      – PersonEntity:
          Name:
            NameFull: Heise MT
      – PersonEntity:
          Name:
            NameFull: Slifka MK
      – PersonEntity:
          Name:
            NameFull: Streblow DN
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 17
              M: 03
              Text: 2025 Mar 17
              Type: published
              Y: 2025
          Identifiers:
            – Type: issn-electronic
              Value: 1935-2735
          Numbering:
            – Type: volume
              Value: 19
            – Type: issue
              Value: 3
          Titles:
            – TitleFull: PLoS neglected tropical diseases
              Type: main
ResultId 1